Positive and negative regulation of Natural Killer cells: Therapeutic implications
- 1 October 2006
- journal article
- review article
- Published by Elsevier BV in Seminars in Cancer Biology
- Vol. 16 (5), 367-382
- https://doi.org/10.1016/j.semcancer.2006.07.003
Abstract
No abstract availableThis publication has 187 references indexed in Scilit:
- CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent mannerThe Journal of Experimental Medicine, 2005
- Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2 /neu-positive breast cancer cellsEuropean Journal of Immunology, 2001
- SYNERGISTIC PROLIFERATION AND ACTIVATION OF NATURAL KILLER CELLS BY INTERLEUKIN 12 AND INTERLEUKIN 18Cytokine, 1999
- Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient MiceImmunity, 1996
- Inhibitory MHC class I receptors on NK cells and T cellsImmunology Today, 1996
- Transforming growth factor‐β inhibits interleukin‐12‐induced production of interferon‐γ by natural killer cells: A role for transforming growth factor‐β in the regulation of T cell‐independent resistance to Toxoplasma gondiiEuropean Journal of Immunology, 1995
- Distribution of perforin‐containing cells in normal and pregnant mice*European Journal of Immunology, 1993
- Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammationProgress in Growth Factor Research, 1992
- Restoration of H-2b expression and processing of endogenous antigens in the MHC class I pathway by fusion of a lymphoma mutant to L cells of the H-2k haplotypeEuropean Journal of Immunology, 1990
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985